6533b834fe1ef96bd129cbb1
RESEARCH PRODUCT
Cytomegalovirus‐specific T‐cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib
Dolores GarcíaEstela GiménezMaría José TerolMaría José TerolAna SausDavid NavarroRafael AndreuBeatriz OleaMaría José RemigiaPaula AmatPaula AmatJavier López-jiménezCarlos SolanoCarlos SolanoLaura FoxCarlos Solano De La AsunciónEliseo Albertsubject
CD4-Positive T-LymphocytesMaleCongenital cytomegalovirus infectionCytomegalovirusT-Cell Antigen Receptor SpecificityCD8-Positive T-LymphocytesViral Matrix Proteinschemistry.chemical_compoundPiperidinesT-Lymphocyte SubsetsT cell immunitymedicineHumansIn patientViremiaProtein Kinase InhibitorsAgedAged 80 and overLymphocytic leukaemiabusiness.industryAdenineHematologyCmv dnaemiaMiddle Agedmedicine.diseaseLeukemia Lymphocytic Chronic B-CellchemistryIbrutinibCytomegalovirus InfectionsDNA ViralImmunologyFemalebusinessInterferon-gamma Release Testsyear | journal | country | edition | language |
---|---|---|---|---|
2021-06-23 | British Journal of Haematology |